欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/1516/003
药品名称Valsartan/Hydrochlorothiazid TAD160 mg/25 mg
活性成分
    • hydrochlorothiazide 25.0 mg
    • valsartan 160.0 mg
剂型Film-coated tablet
上市许可持有人TAD Pharma GmbH Heinz-Lohmann-Strasse 5 27472 Cuxhaven Germany Change of RMS: NEW: CZ/H/0233/01-03/MR Change of RMS: New: CZ/H/0233/DC Change of RMS: new: CZ/H/0233/01-03/DC 11.11.2009 Change of RMS: New procedure number: CZ/H/233/01-03/DC
参考成员国 - 产品名称Germany (DE)
Valsartan/Hydrochlorothiazid TAD 160 mg/ 25 mg Filmtabletten
互认成员国 - 产品名称
    • Denmark (DK)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Austria (AT)
      Valsartan/Hydrochlorothiazid Krka 160 mg/25 mg Filmtabletten
    • Spain (ES)
    • Greece (GR)
    • Sweden (SE)
      Valsartan/Hydrochlorothiazide Krka
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
    • Latvia (LV)
      Valsacombi 160 mg/25 mg apvalkotās tabletes
    • Lithuania (LT)
      Valsacombi 160 mg/25 mg plėvele dengtos tabletės
    • Estonia (EE)
    • Hungary (HU)
      Co-Valsacor 160/25 mg
    • Bulgaria (BG)
      Co-Valsacor
    • Czechia (CZ)
      Valsacombi 160 mg/25 mg potahovaná tableta
    • Slovakia (SK)
      Co-Valsacor 160 mg/25 mg filmom obalené tablety
    • Slovenia (SI)
      Valsacombi 160 mg/25 mg filmsko obložene tablete
许可日期2009/05/26
最近更新日期2011/10/27
药物ATC编码
    • C09DA03 valsartan and diuretics
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase